Early Tumor Shrinkage Under Treatment with First-line Tyrosine Kinase Inhibitors as a Predictor of Overall Survival in Patients with Metastatic Renal Cell Carcinoma: a Retrospective Multi-Institutional Study in Japan.
about
Overall survival of first-line axitinib in metastatic renal cell carcinoma: Japanese subgroup analysis from phase II studyAnaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.Prognostic Significance of Early Tumor Shrinkage Under Second-Line Targeted Therapy for Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Study in Japan.Early primary renal tumor response predicts clinical outcome in patients with primary unresectable renal cell carcinoma with synchronous distant metastasis receiving molecularly targeted therapies.Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy.
P2860
Early Tumor Shrinkage Under Treatment with First-line Tyrosine Kinase Inhibitors as a Predictor of Overall Survival in Patients with Metastatic Renal Cell Carcinoma: a Retrospective Multi-Institutional Study in Japan.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Early Tumor Shrinkage Under Tr ...... -Institutional Study in Japan.
@en
Early Tumor Shrinkage Under Tr ...... -Institutional Study in Japan.
@nl
type
label
Early Tumor Shrinkage Under Tr ...... -Institutional Study in Japan.
@en
Early Tumor Shrinkage Under Tr ...... -Institutional Study in Japan.
@nl
prefLabel
Early Tumor Shrinkage Under Tr ...... -Institutional Study in Japan.
@en
Early Tumor Shrinkage Under Tr ...... -Institutional Study in Japan.
@nl
P2093
P2860
P1433
P1476
Early Tumor Shrinkage Under Tr ...... -Institutional Study in Japan.
@en
P2093
Akira Miyazaki
Hideaki Miyake
Ken-Ichi Harada
Masato Fujisawa
Satoshi Imai
P2860
P2888
P304
P356
10.1007/S11523-015-0385-6
P577
2015-09-04T00:00:00Z